The HICCC is pleased to announce a fifth Irving Cancer Drug Discovery Program (ICDDP) project, designed to help faculty accelerate cancer research discoveries.
HICCC's research team, led by Carla Concepcion-Crisol, PhD (PI); and Benjamin Herzberg, MD, will focus on evaluating SMARCA4-mutant non-small cell lung cancer.
New support from the MacMillan Family Foundation will address the urgent need for targeted interventions and community-driven solutions for disparities in cancer care.
A congratulations to Dr. Gaublomme who has received a prestigious NIH Director's New Innovator Award for work that pushes the boundaries in cancer research.
Congratulations to Lauren Houghton, Chin Hur, Markus D. Siegelin, and Neil Vasan, the new Class of Velocity Fellows, for their innovative, life-changing cancer research.
New awards program supports cutting-edge research dedicated to the study and treatment of MDS, a malignant disease that attacks bone marrow stem cells.
With a new three-year, $775,000 Translational Research Program grant by The Leukemia & Lymphoma Society, Dr. Lentzsch and collaborators unveil a promising new approach to treat multiple myeloma.
Columbia Cancer congratulates Drs. Catherine Spina and Aaron Viny, recipients of a prestigious Clinical Scientist Development Award by the Doris Duke Charitable Foundation.
Annual Precision Medicine Pilot Grants are awarded to five Columbia research teams, including research led by members Drs. Brent Stockwell and Kelley Yan.
A multi-institution team of lung cancer experts have received a new SU2C grant to bring technology-enabled immunotherapy monitoring to under-represented patients.